Showing 2321-2330 of 4065 results for "".
Incorporating Targeted Therapies in Treatment Planning for AAV
https://reachmd.com/programs/cme/incorporating-targeted-therapies-in-treatment-planning-for-aav/14962/Our experts offer tips to effectively manage your patients with AAV & improve their quality of life by incorporating C5a receptor antagonist therapy.Elevating CKD-aP Care: New Frontier
https://reachmd.com/programs/cme/elevating-ckd-ap-care-new-frontier/36298/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
https://reachmd.com/programs/cme/clinical-evidence-on-monotherapy-with-menin-inhibitors-in-rr-aml/36180/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Decoding Itch in CKD: From CKD-aP Suspicion to Solution
https://reachmd.com/programs/cme/decoding-itch-in-ckd-from-ckd-ap-suspicion-to-solution/26640/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Cracking the Code of Obstruction: Unmet Needs in oHCM
https://reachmd.com/programs/cme/cracking-the-code-of-obstruction-unmet-needs-in-ohcm/54837/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.VNS: Beyond Seizure Control
https://reachmd.com/programs/cme/vns-beyond-seizure-control/35795/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Navigating the LGMD2I/R9 Diagnostic Pathway
https://reachmd.com/programs/cme/navigating-the-lgmd2ir9-diagnostic-pathway/35879/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
https://reachmd.com/programs/cme/modern-obstructive-hcm-care-from-unmet-needs-to-individualized-myosin-inhibitor-therapy/56979/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.Kappa-Opioid Settings: Real-World Evidence Insights
https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Is CKD-aP Hiding in Your Dialysis Center?
https://reachmd.com/programs/cme/is-ckd-ap-hiding-in-your-dialysis-center/36299/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.